Explore PMOS Research
Search 20,710 PMOS papers published between 2015 and 2025. Filter by research topic, country, year range, or co-investigated condition to find where the field is active and where the gaps are.
Total citations
289,983
Peak year
2025(3,021 articles)
Avg citations / article
14
Publications per year
Topics
All research areas ⓘArticle mentionsA paper tagged with multiple topics counts once in each. The Overview uses fractional counting instead. See methodology.
Countries
All countries
Top journals
All filters
Top institutions
All filters
Where in the world is each topic being researched?
Toggle between Revealed Comparative Advantage (RCA), a specialisation index where values above 1.0 mean a country focuses on that topic more than average, and raw article counts.
| Hormones | Metabolic | Fertility | Epidemiol. | Pharma | Diagnos. | Genetics | Mental | Nutrition | Molecular | Inflamm. | Cell Bio | Lifestyle | Microbiome | Dermatol. | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| China | 1.0 | 0.9 | 1.1 | 0.9 | 1.1 | 0.7 | 1.5 | 0.4 | 0.7 | 1.9 | 1.1 | 2.1 | 0.5 | 1.4 | 0.2 |
| United States | 1.0 | 1.1 | 1.0 | 1.3 | 0.8 | 1.1 | 0.9 | 1.4 | 0.6 | 0.6 | 0.7 | 0.6 | 1.0 | 0.6 | 1.3 |
| India | 0.9 | 0.9 | 0.9 | 0.9 | 0.9 | 1.9 | 1.1 | 1.1 | 1.7 | 0.8 | 0.7 | 0.6 | 1.2 | 1.2 | 1.9 |
| Iran | 1.0 | 0.9 | 0.9 | 0.9 | 1.6 | 0.5 | 0.7 | 1.2 | 1.8 | 0.9 | 2.0 | 0.7 | 1.1 | 0.9 | 0.8 |
| Turkey | 1.2 | 1.2 | 0.8 | 0.4 | 0.4 | 1.4 | 0.5 | 1.0 | 1.0 | 0.6 | 1.7 | 0.5 | 0.4 | 1.3 | 1.4 |
| United Kingdom | 0.9 | 1.0 | 0.9 | 1.3 | 1.0 | 0.9 | 0.8 | 2.0 | 0.9 | 0.5 | 0.7 | 0.3 | 1.8 | 0.5 | 1.3 |
| Australia | 0.8 | 1.1 | 0.9 | 1.9 | 1.1 | 0.8 | 0.6 | 2.1 | 0.7 | 0.2 | 0.1 | 0.5 | 4.0 | 0.4 | 0.5 |
| Italy | 1.1 | 1.2 | 1.0 | 0.8 | 0.9 | 1.2 | 0.5 | 0.8 | 1.5 | 0.6 | 0.7 | 0.3 | 0.5 | 1.0 | 1.0 |
| Egypt | 1.0 | 0.8 | 1.9 | 0.4 | 1.7 | 0.8 | 0.4 | 0.6 | 1.1 | 0.6 | 1.0 | 0.5 | 0.3 | 0.3 | 2.2 |
| Poland | 1.3 | 1.4 | 0.5 | 0.6 | 0.4 | 0.8 | 0.6 | 1.2 | 0.8 | 0.6 | 1.2 | 0.4 | 1.1 | 1.7 | 1.6 |
Studies8,341–8,360 of 20,710
All studies
Behandlungen zur Verbesserung der psychischen Gesundheit beim PCOS
THU636 Prevalence Of Metabolic Syndrome In A Sample Of Hispanic Patients With Polycystic Ovary Syndrome
Review for "The presence of polycystic ovary syndrome increases the risk of maternal but not neonatal complications in women with type 2 diabetes in pregnancy"
Eating behavior, physical activity, and exercise training in adolescent polycystic ovary syndrome
EFFECT OF GLUCAGON-LIKE PEPTIDE 1 RECEPTOR AGONIST PHARMACOTHERAPY ON WEIGHT LOSS IN PATIENTS WITH AND WITHOUT POLYCYSTIC OVARY SYNDROME
Inadvertent surgical bleeding in PCOS patient with splenomegaly and its association with Non Alcoholic Fatty Liver Disease (NAFLD)
Unveiling Novel Frontiers in Polycystic Ovary Syndrome Management
SAT379 Potassium Levels in Women with PCOS Using Spironolactone for Long-term
Microbiology of Follicular Fluid Aspirated in Women with Polycystic Ovarian Syndrome (PCOS) Attending Fertility Clinic on Southern Part of Nigeria
POLYCYSTIC OVARY SYNDROME, LACTOGENESIS AND BREASTFEEDING
Peri- and postmenopause in patients with Polycystic Ovarian Syndrome (PCOS)
The Bone Mineral Density of the Skull and its relation with Subdural Hematoma in Craniofacial Trauma in Women With Polycystic Ovary Syndrome (PCOS)
Low-dose pioglitazone for polycystic ovary syndrome in adolescent girls: differential fat-mass redistribution by HOTAIR rs1443512 genotype
Association of Metabolic Syndrome in Polycystic Ovary Syndrome: Prevalence and Correlation with Infertility - An Overview
Propionate is a Signature in Insulin Resistance Patients with Polycystic Ovary Syndrome
Editor's evaluation: Direct economic burden of mental health disorders associated with polycystic ovary syndrome: Systematic review and meta-analysis
Acetate supplementation improves adipose-hepatic gluco-lipid dysregulation in experimental PCOS model by repression of NF- κB/NLRP3 immunoreactivity
Holistic treatment for PCOS patients: patient perspective, physicians perspective